[go: up one dir, main page]

AR052262A1 - PHENYLPIRAZOL-PIPERAZINAS AND IMPORTANT PESTICID COMPOSITIONS OF THE SAME - Google Patents

PHENYLPIRAZOL-PIPERAZINAS AND IMPORTANT PESTICID COMPOSITIONS OF THE SAME

Info

Publication number
AR052262A1
AR052262A1 ARP050105119A ARP050105119A AR052262A1 AR 052262 A1 AR052262 A1 AR 052262A1 AR P050105119 A ARP050105119 A AR P050105119A AR P050105119 A ARP050105119 A AR P050105119A AR 052262 A1 AR052262 A1 AR 052262A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
substituted
haloalkyl
alkynyl
Prior art date
Application number
ARP050105119A
Other languages
Spanish (es)
Original Assignee
Bayer Cropscience Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Sa filed Critical Bayer Cropscience Sa
Publication of AR052262A1 publication Critical patent/AR052262A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un proceso para su preparacion, a composiciones de los mismos y a su uso para el control de plagas, incluyendo artropodos y helmintos. Derivados de 5-diazacicloalquilpirazol de formula (1), donde: R1 es CN, CH3, CF3, C(=N-Z)p-alquiloC1-4 y CSNH2; donde Z es H, alquilo C1-6, haloalquilo C1-6, alquenilo C3-6, alquinilo C3-6, -(CH2)qR8, COR9, CO2-alquiloC1-6 o S(O)pR9; R2 es halogeno, CH3 o NR11R12; R3 es haloalquilo C1-3, haloalcoxi C1-3 o SF5; R4 es hidrogeno, alquenilo C2-6, haloalquenilo C2- 6, alquinilo C2-6, haloalquinilo C2-6, cicloalquilo C3-7, cicloalquilC3-7-alquiloC1-6, CO2-alquiloC1-6, CO2-alqueniloC3-6, CO-alquiniloC3.6, CO2.(CH2)qR10, CO2-(CH2)qR10, CONR6R7 y SO2R9; formilo, CO-CO2-alquiloC1-6 o CO-alquiloC1-6 no sustituido o sustituido con uno o más radicales seleccionados del grupo que incluye halogeno, alcoxi C1-6, haloalcoxi C1-6, alqueniloxi C3-6, haloalqueniloxi C3-6, alquiniloxi C3-6, haloalquiniloxi C3-6, cicloalquilo C3-4, S(O)pR9, CN, NO2, OH, R8, R10, COR9, NR6R76, OR9 y CO2R9; o CO-(CH2)mR8; o CO-(CH2)mR10; o alquilo C1-6 no sustituido o sustituido con uno o más radicales seleccionados del grupo que incluye halogeno, alcoxi C1-6, haloalcoxi C1-6, alqueniloxi C3-6, haloalqueniloxi C3-6, alquiniloxi C3- 6, haloalquiniloxi C3-6, cicloalquilo C3-7, S(O)oR9, CN, NO2, O, R8, R10, COR9, NR6R7, OR9, COOH y CO2R9; o R8 y R10; R5 es alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, haloalquenilo C2-6, alquinilo C2-6 o haloalquinilo C2-6; A es alquileno C1-6 o alquenileno C2-6 cuyos grupos no están sustituidos o están sustituidos con uno o más alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, haloalquenilo C2-6, alquinilo C2-6, haloalquinilo C2-6, cicloalquilo C3-7, cicloalquilC3-7-alquiloC1-4, (CH2)qR8 o (CH2)qR10; E es alquileno C2-6 o alquenileno C2-6 cuyos grupos no están sustituidos o están sustituidos con uno o más alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, haloalquenilo C2-6, alquinilo C2-6, haloalquinilo C2-6, cicloalquilo C3-7, cicloalquilC3-7-alquiloC1-4, (CH2)qR8 o (CH2)qR10; y donde A y E pueden estar enlazados para formar un sistema bicíclico; R6 y R7 es cada uno de modo independiente H, alquilo C1-6, haloalquilo C1-6, alquenilo C2-6, haloalquenilo C2-6, alquinilo C2- 6, haloalquinilo C2-6, cicloalquilo C3-7, cicloalquilC3-7-alquiloC1-4, (CH2)qR8 o (CH2)qR10; R6 y R7 puede formar junto con el átomo N unido un anillo saturado de cuatro a siete miembros y un anillo insaturado de cinco a siete miembros, cuyo anillo contiene opcionalmente uno y más heteroátomos adicionales en el anillo que son seleccionados de O, S y N, estando el anillo no sustituido o sustituido con uno y más radicales seleccionados del grupo que incluye halogeno, alquilo C1-6, haloalquilo C1- 6 y oxo, y cuando existe cualquier átomo N cíclico adicional no está sustituido y está sustituido con un alquilo C1-6, CO-alquiloC1-6 o un radical CH2R11; R8 es fenilo no sustituido o está sustituido con uno y más radicales seleccionados del grupo que incluye halogeno, alquilo C1-6, haloalquilo C1-6, alcoxi C1-6, haloalcoxi, CN, NO2, S(O)pR9 y NR6R7; R9 es alquilo C1-6, haloalquilo C1-6, cicloalquilo C3-7, -alquilC14-cicloalquiloC3-7, -(CH2)qR8 o -(CH2)qR10; R10 es heterociclilo no sustituido o está sustituido con uno y más radicales seleccionados del grupo que incluye halogeno, alquilo C1-4, haloalquilo C1-4, alcoxi C1-4, S(O)pR9, OH y oxo; R11 y R12 son cada uno de modo independiente H, alquilo C1-6, alquenilo C2-6 o alquinilo C2-6, cuyos ultimos tres grupos mencionados están no sustituidos o están sustituidos con uno y más radicales seleccionados del grupo que incluye halogeno, cicloalquilo C3-7, R8, R10, alcoxi C1-6, haloalcoxi C1-5; n, p y q son cada uno de modo independiente cero uno o dos; m es cero, uno, dos o tres; y cada heterociclilo en los radicales que se mencionaron precedentemente es independientemente un radical heterocíclico que presenta 3 a 7 átomos cíclicos y 1, 2 y 3 heteroátomos en el anillo seleccionado del grupo que incluye N, O y S; o una sal de los mismos aceptable para su uso como plaguicida.A process for its preparation, its compositions and its use for pest control, including arthropods and helminths. 5-Diazacycloalkylpyrazole derivatives of formula (1), wherein: R1 is CN, CH3, CF3, C (= N-Z) p-C1-4alkyl and CSNH2; where Z is H, C1-6 alkyl, C1-6 haloalkyl, C3-6 alkenyl, C3-6 alkynyl, - (CH2) qR8, COR9, CO2-C1-6 alkyl or S (O) pR9; R2 is halogen, CH3 or NR11R12; R3 is C1-3 haloalkyl, C1-3 haloalkoxy or SF5; R4 is hydrogen, C2-6 alkenyl, C2-6 haloalkenyl, C2-6 alkynyl, C2-6 haloalkynyl, C3-7 cycloalkyl, C3-7 cycloalkylC1-6, CO2-C1-6 alkyl, CO2-C3-6 alkenyl, CO -C3.6 alkynyl, CO2. (CH2) qR10, CO2- (CH2) qR10, CONR6R7 and SO2R9; formyl, CO-CO2-C 1-6 alkyl or CO-C 1-6 alkyl unsubstituted or substituted with one or more radicals selected from the group including halogen, C 1-6 alkoxy, C 1-6 haloalkoxy, C 3-6 alkenyloxy, C 3-6 haloalkenyloxy , C3-6 alkynyloxy, C3-6 haloalkyloxy, C3-4 cycloalkyl, S (O) pR9, CN, NO2, OH, R8, R10, COR9, NR6R76, OR9 and CO2R9; or CO- (CH2) mR8; or CO- (CH2) mR10; or C1-6 alkyl unsubstituted or substituted with one or more radicals selected from the group including halogen, C1-6 alkoxy, C1-6 haloalkoxy, C3-6 alkenyloxy, C3-6 haloalkyloxy, C3-6 alkynyloxy, C3-6 haloalkyloxy , C3-7 cycloalkyl, S (O) or R9, CN, NO2, O, R8, R10, COR9, NR6R7, OR9, COOH and CO2R9; or R8 and R10; R 5 is C 1-6 alkyl, C 1-6 haloalkyl, C 2-6 alkenyl, C 2-6 haloalkenyl, C 2-6 alkynyl or C 2-6 haloalkynyl; A is C1-6 alkylene or C2-6 alkenylene whose groups are not substituted or substituted with one or more C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 haloalkenyl, C2-6 alkynyl, C2 haloalkynyl -6, C3-7 cycloalkyl, C3-7 cycloalkyl-C1-4alkyl, (CH2) qR8 or (CH2) qR10; E is C2-6 alkylene or C2-6 alkenylene whose groups are not substituted or substituted with one or more C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 haloalkenyl, C2-6 alkynyl, C2 haloalkynyl -6, C3-7 cycloalkyl, C3-7 cycloalkyl-C1-4alkyl, (CH2) qR8 or (CH2) qR10; and where A and E may be linked to form a bicyclic system; R 6 and R 7 are each independently H, C 1-6 alkyl, C 1-6 haloalkyl, C 2-6 alkenyl, C 2-6 haloalkenyl, C 2-6 alkynyl, C 2-6 haloalkynyl, C 3-7 cycloalkyl, C 3-7 cycloalkyl C1-4alkyl, (CH2) qR8 or (CH2) qR10; R6 and R7 can form together with the attached N atom a saturated ring of four to seven members and an unsaturated ring of five to seven members, whose ring optionally contains one and more additional heteroatoms in the ring that are selected from O, S and N , the ring being unsubstituted or substituted with one and more radicals selected from the group including halogen, C1-6 alkyl, C1-6 haloalkyl and oxo, and when there is any additional cyclic N atom it is not substituted and is substituted with a C1 alkyl -6, CO-C1-6 alkyl or a CH2R11 radical; R8 is unsubstituted phenyl or is substituted by one and more radicals selected from the group including halogen, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, haloalkoxy, CN, NO2, S (O) pR9 and NR6R7; R9 is C1-6 alkyl, C1-6 haloalkyl, C3-7 cycloalkyl, -C14 alkyl-C3-7 cycloalkyl, - (CH2) qR8 or - (CH2) qR10; R10 is unsubstituted heterocyclyl or is substituted with one and more radicals selected from the group including halogen, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, S (O) pR9, OH and oxo; R11 and R12 are each independently H, C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl, whose last three groups mentioned are unsubstituted or substituted with one and more radicals selected from the group including halogen, cycloalkyl C3-7, R8, R10, C1-6 alkoxy, C1-5 haloalkoxy; n, p and q are each independently zero one or two; m is zero, one, two or three; and each heterocyclyl in the radicals mentioned above is independently a heterocyclic radical having 3 to 7 cyclic atoms and 1, 2 and 3 heteroatoms in the ring selected from the group that includes N, O and S; or a salt thereof acceptable for use as a pesticide.

ARP050105119A 2004-12-07 2005-12-07 PHENYLPIRAZOL-PIPERAZINAS AND IMPORTANT PESTICID COMPOSITIONS OF THE SAME AR052262A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04028995 2004-12-07

Publications (1)

Publication Number Publication Date
AR052262A1 true AR052262A1 (en) 2007-03-07

Family

ID=34927681

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105119A AR052262A1 (en) 2004-12-07 2005-12-07 PHENYLPIRAZOL-PIPERAZINAS AND IMPORTANT PESTICID COMPOSITIONS OF THE SAME

Country Status (9)

Country Link
US (1) US7678797B2 (en)
EP (1) EP1841744B1 (en)
JP (1) JP4999104B2 (en)
CN (1) CN101175729B (en)
AR (1) AR052262A1 (en)
BR (1) BRPI0518942A2 (en)
CA (1) CA2588148C (en)
ES (1) ES2515099T3 (en)
WO (1) WO2006061147A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2515099T3 (en) * 2004-12-07 2014-10-29 Merial Limited 1-phenyl-3-piperazin-pyrazoles and pesticidal compositions thereof
RU2596185C2 (en) * 2010-09-29 2016-08-27 Интервет Интернэшнл Б.В. N-heteroaryl compounds
US9260441B2 (en) 2012-03-28 2016-02-16 Intervet Inc. Heteroaryl compounds with cyclic bridging unit
CN105541821B (en) * 2016-01-28 2018-05-18 中南民族大学 Oxazine assimilation arylpyrazole type compound and its Ultrasonic Radiation synthetic method and application
EP3411395B1 (en) 2016-02-01 2020-04-15 Bayer Animal Health GmbH Rhipicephalus nicotinic acetylcholine receptor and pest control acting thereon
WO2020163689A1 (en) 2019-02-08 2020-08-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education 20-hete formation inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
DE3545036A1 (en) * 1985-12-19 1987-09-10 Bayer Ag 5-HETEROCYCLYL-1-ARYL-PYRAZOLE
GB8816915D0 (en) * 1988-07-15 1988-08-17 May & Baker Ltd New compositions of matter
DE4343832A1 (en) * 1993-12-22 1995-06-29 Bayer Ag Substituted 1-arylpyrazoles
ES2515099T3 (en) * 2004-12-07 2014-10-29 Merial Limited 1-phenyl-3-piperazin-pyrazoles and pesticidal compositions thereof

Also Published As

Publication number Publication date
CN101175729A (en) 2008-05-07
ES2515099T3 (en) 2014-10-29
WO2006061147A1 (en) 2006-06-15
CA2588148C (en) 2013-02-19
JP4999104B2 (en) 2012-08-15
US20080113998A1 (en) 2008-05-15
CA2588148A1 (en) 2006-06-15
EP1841744B1 (en) 2014-09-24
CN101175729B (en) 2011-06-01
US7678797B2 (en) 2010-03-16
BRPI0518942A2 (en) 2008-12-16
EP1841744A1 (en) 2007-10-10
JP2008522961A (en) 2008-07-03

Similar Documents

Publication Publication Date Title
AR044614A1 (en) SULFONAMIDE COMPOSITIONS THAT MODULATE THE ACTIVITY OF THE KINIOQUIN RECEIVER (CCR4)
CO6160230A2 (en) ARILSULPHONAMIDS WITH ANALGESIC EFFECT
AR063331A1 (en) DERIVATIVES OF BIARIL ETER UREA AND PHARMACEUTICAL COMPOSITIONS
AR064258A1 (en) HEPATITIS C VIRUS MACROCICLIC INHIBITORS
AR035617A1 (en) COMPOUNDS DERIVED FROM PHENETHANOLAMINE, COMBINATIONS AND PHARMACEUTICAL FORMULATIONS OF THE SAME, PROCESS FOR THEIR PREPARATION, ITS USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OR PROPHYLAXIS OF A CLINICAL CONDITION FOR WHICH A BETAIEPAR BARDIAR AGENT IS ADDED
AR079224A1 (en) INSECTICIDE COMPOUNDS BASED ON ISOXAZOLINE DERIVATIVES
AR059516A1 (en) ISOXAZOLINE DERIVATIVES, OBTAINING PROCESSES AND HERBICIDE COMPOSITIONS
AR061548A1 (en) 3-AMINOPIRROLIDINO-4-REPLACED LACTAMAS AS INHIBITORS OF DIPEPTIDILPEPTIDASA IV (DPP-IV), PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME IN THE TREATMENT OF DIABETES II.
AR063684A1 (en) DERIVATIVES OF 4, 4´-BIFENILDIILBIS (1H-IMIDAZOL-5, 2-DIIL) AS INHIBITORS OF THE HEPATITIS C VIRUS, COMPOSITION THAT INCLUDES THEM AND ITS USE TO TREAT AN INFECTION WITH HCV.
AR076200A1 (en) ISOXAZOLINE COMPOUNDS TO COMBAT INVERTEBRATE PESTS
CO6140056A2 (en) AMINO COMPOUNDS -5-4 (DIFLUOROMETOXI) SUBSTITUTED PHENYL-5-PHENYLIMIDAZOLONE AS BETA INHIBITORS -SECRETASA
AR051734A1 (en) REGULATION OF GROWTH OF PLANTS BY DERIVATIVES OF 2-AMINO-6-OXIPURINE. COMPOSITIONS
AR049559A1 (en) 3-AMINOCICLOPENTANCARBOXAMIDS AS CHEMIOQUINE RECEPTORS MODULATORS
AR067060A1 (en) POLYCLYCAN GUANINE DERIVATIVES AND THEIR METHODS OF USE
AR051089A1 (en) TRIAZOLOQUINOLEINE AND TRIAZOLONAFTIRIDINE SUBSTITUTED COMPOUNDS
AR048789A1 (en) DERIVATIVES OF OXAZOL AND ITS COMPOSITIONS AS MODULATORS OF ACTIVATED RECEIVER OF PEROXISOM PROLIFERATOR (PPAR)
AR052568A1 (en) DERIVATIVES OF PIRAZOLO-PYRIMIDINE AS ANGLOSTS OF MGLUR2
AR061792A1 (en) HETEROCICLIC DERIVATIVES AND ITS USE IN THE TREATMENT OR PREVENTION OF PSYCHIATRIC DISEASES WHERE AN INCREASE OF SYNAPTIC RESPONSES MEASURED BY AMPA RECEPTORS IS REQUIRED
AR042827A1 (en) CONDENSED FURANO COMPOUNDS
AR043432A1 (en) DERIVATIVES OF REPLACED AMINO ACIDS WITH CYCLLOQUAL, PROCEDURE FOR PREPARATION AND USE AS MEDICATIONS
AR054529A1 (en) BENZAZEPIN DERIVATIVES AS 5-HYDROXY-TRIPTAMINE 6 RECEPTOR MODULATORS
AR052262A1 (en) PHENYLPIRAZOL-PIPERAZINAS AND IMPORTANT PESTICID COMPOSITIONS OF THE SAME
AR059136A1 (en) DERIVATIVES OF INDOL-3-IL-CARBONIL-ESPIRO-PIPERIDINA
AR053149A1 (en) USE OF DIOSMETINE COMPOUNDS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE PREVENTION AND / OR TREATMENT OF THROMBOTIC PATHOLOGIES AND PATHOLOGIES THAT CONCLUDE THE RISK OF PRODUCING THROMBOSIS
CO5690598A2 (en) 6 - [(REPLACED) PHENYL] TRIAZOLOPIRIMIDINAS AS ANTICANCER AGENTS

Legal Events

Date Code Title Description
FG Grant, registration